Objective: Squamous intraepithelial lesions (SILs) are classified as low-grade SIL (LGSIL) and high-grade SIL (HGSIL). ‘LGSIL cannot exclude high grade’ (LGSIL-H) interpretive category has been used in cases where findings exceed criteria for LGSIL, but do not fulfill the criteria for HGSIL. This study analyzed follow-up histology of LGSIL-H cases and compared the follow-up results of LGSIL-H with LGSIL to determine the utility of LGSIL-H category using a single institution’s experience. Study Design: Pap smears with LGSIL-H interpretation from 2005 to 2008 were retrieved. Histological follow-up results for LGSIL-H cases were analyzed and compared to the follow-up results of LGSIL cases. Results: Cases with LGSIL-H interpretation (311) comprised 0.18% of all cases (170,307). Follow-up was available for 144 patients and 13.2% had benign findings, 51.4% had cervical intraepithelial neoplasia (CIN) 1, and 35.4% had CIN 2 or higher. In comparison, of 425 patients with LGSIL, 22.6% had benign findings, 71% had CIN 1 and 6.4% had CIN 2 or higher. Conclusion: A significantly greater number of patients with LGSIL-H interpretation had a CIN 2 or higher lesion on follow-up compared to patients with LGSIL. This suggests LGSIL-H may be a useful diagnostic category.

Keywords:
Cytopathology, Squamous intraepithelial lesions, Cervical intraepithelial neoplasia
1.
Solomon D, Davey D, Kurman R, et al: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114–2119.
2.
Solomon D, Nayar R (eds): The Bethesda System for Reporting Cervical Cytology. New York, Springer, 2004.
3.
Wright TC, Massad SL, Dunton CJ, et al: 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 2007;11:201–222.
4.
McGrath CM, Kurtis JD, Yu GH: Evaluation of mild-to-moderate dysplasia on cervical-endocervical (Pap) smear: a subgroup of patients who bridge LSIL and HSIL. Diagn Cytopathol 2000;23:245–248.
5.
Nasser SM, Cibas ES, Crum CP, Faquin WC: The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion. Cancer 2003;99:272–276.
6.
Saab BA, Austin RM: Management of squamous intraepithelial lesions of indeterminate grade. Am J Obstet Gynecol 2008;199;e13–e14.
7.
Elsheikh TM, Kirkpatrick JL, Wu HH: The significance of ‘low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion’ as a distinct squamous abnormality category in Papanicolaou tests. Cancer 2006;108:277–281.
8.
Alsharif M, Kjeldahl K, Curran C, Miller S, Gulbahce HE, Pambuccian SE: Clinical significance of the diagnosis of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion. Cancer Cytopathol 2009;117:92–100.
9.
Owens CL, Moats DR, Burroughs FH, Gustafson KS: ‘Low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion’ is a distinct cytologic category: histologic outcomes and HPV prevalence. Am J Clin Pathol 2007;128:398–403.
10.
Hong RH, Kim BM, Kim HS, Chun YK, Kim HS: Evaluation of low-grade squamous intraepithelial lesions, cannot exclude high-grade squamous intraepithelial lesions on cervical smear. Kor J Pathol 2010;44:528–535.
11.
Jones BA, Novis DA: Cervical biopsy-cytology correlation: a College of American Pathologists Q-Probes study of 22,439 correlations in 348 laboratories. Arch Pathol Lab Med 1996;120:523–531.
12.
Shidham VB, Kumar N, Narayan R, Brotzman GL: Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on SurePath specimens with review of literature. Cytojournal 2007;4:7.
13.
Ince U, Aydin O, Peker O: Clinical importance of ‘low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H)’ terminology for cervical smears 5-year analysis of the positive predictive value of LSIL-H compared with ASC-H, LSIL, and HSIL in the detection of high-grade cervical lesions with a review of the literature. Gynecol Oncol 2011;121:152–156.
14.
Difurio M, Mailhiot T, Sundborg M, Nauschuetz K: Comparison of the clinical significance of the Papanicolau test interpretations LSIL cannot rule out HSIL and ASC-H. Diagn Cytopathol 2010;38:313–317.
15.
The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group: Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 2000;92:397–402.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.